{
  "@context": "aku-v2",
  "@type": "clinical-concept",
  "@id": "vasc:wound:biofilm-management",
  "metadata": {
    "version": "2.0.0",
    "created": "2026-01-07T03:25:00.000Z",
    "updated": "2026-01-07T03:25:00.000Z",
    "contributors": ["knowledge-graph-agent"],
    "confidence": 0.90,
    "status": "pending-quality-check"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/wound-care",
    "type": "wound-management",
    "difficulty": "intermediate",
    "importance": "high"
  },
  "content": {
    "title": "Biofilm Management in Chronic Wounds",
    "description": "Recognition and treatment of bacterial biofilms in chronic wounds",
    "key_concepts": [
      {
        "concept": "Definition",
        "details": "Organized bacterial communities encased in extracellular polymeric substance (EPS)"
      },
      {
        "concept": "Clinical Signs",
        "details": "Recalcitrant wound, slough despite debridement, increased exudate, failure to respond to antibiotics"
      },
      {
        "concept": "Disruption Strategies",
        "details": "Sharp debridement, surfactant-based cleansers, antimicrobial dressings"
      },
      {
        "concept": "Maintenance",
        "details": "Biofilm reforms within 24-48 hours; requires ongoing disruption strategy"
      }
    ],
    "clinical_significance": "Biofilm present in estimated 60-80% of chronic wounds"
  },
  "provenance": {
    "primary_sources": ["Wolcott R et al. J Wound Care 2010"]
  }
}
